Zydus Cadila open for buyouts in the US

Denies reports of looking to acquire Sentynl Therapeutics

Zydus
Zydus
Sohini Das Ahmedabad
Last Updated : Jan 19 2017 | 1:35 AM IST

Don't want to miss the best from Business Standard?


 
Zydus' acquisition trail:

1995- Acquired Indo Pharma Pharmaceutical Works Ltd. Indo Pharma (later re-named as Indon) was a 56-year-old company.

2000- Acquired Recon Healthcare. This strategic move boosted the group's strengths in the southern markets of India.

2001- Acquired German Remedies Ltd. With this, Zydus gained leadership in the women's healthcare, respiratory and oncology segments.

Also Read


2001- Acquired Aten. This helped Zydus Cadila to reach the top slot in the cardiovascular segment

2002- Acquired Banyan Chemicals, a company with and USFDA approved API plant

2003- Acquired Alpharma France SAS. This was the first overseas acquisition of the group

2006 - Acquired Carnation Nutra-Analogue Foods Ltd, which manufactures Nutralite - India's largest selling premium margarine.

2007- Acquired Liva Healthcare. This enabled the group to make a strategic foray in the Rs 1,500-crore derma market.

2007- Acquired Quimica e Farmaceutica Nikkho do Brasil Ltda. (Nikkho).

2007- Zydus Cadila entered into a share purchase agreement with Ambalal Sarabhai Enterprises to acquire the remaining 50% holding in the joint venture company, Sarabhai Zydus Animal Health Ltd., making it a 100% subsidiary company of the group.

2008- Acquired Laboratorios Combix, Spain, Simayla Pharmaceuticals of South Africa and Etna Biotech of Italy

2009- Acquired remaining 30% shareholding of Simayla Pharmaceuticals, South Africa making it a 100% subsidiary of the group

2011- Zydus Pharmaceuticals USA Inc., through its subsidiary Zynesher Pharmaceuticals USA LLC entered into an agreement to acquire the assets of the US-based pharmaceutical company Nesher Pharmaceuticals Inc.

2011- Cadila Healthcare Ltd., through its 100% subsidiary Zydus Animal Health Limited (AHL) signed a Share Purchase Agreement with ICICI Venture, to acquire 100% shareholding of Finest Procuring Solutions Limited, which in turn holds 100% shareholding of Bremer Pharma GmbH, of Germany 

2011- Acquired 100% stake in Biochem, one of the top 40 pharma companies in India 

2016- Expanded the animal health business with the acquisition of the manufacturing operations and select brands of Zoetis, a global animal health company

2016 - Acquired the brand, Actibile from Albert David Limited, strengthening its presence in the gastro segment

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story